Eradigm team

Manager, US Lead

Nikoletta Gkatza

Focus Therapy Areas: Oncology, Immunology, Rare Diseases, MedTech

Specialist Expertise: Corporate Strategy, Market Access, Clinical Trial Design, Non-clinical Differentiation, Digital Innovation

Education: BSc Biology (with a Year-In-Industry) – University of York; PhD Stem Cell & Cancer Genetics – University of Cambridge

What is your focus at Eradigm?

I bridge my scientific background with commercial expertise to deliver on projects involving Competitive Intelligence, Corporate Strategy or Market Access to challenge and shape broad-level strategy. My main focus is to become a thought partner to our clients and ensure that we continue adding value to every discussion across the business (including Eradigm). 

Who do you work with?

I primarily work with global intelligence & strategy leads, therapeutic area or brand-level directors across top 20 biopharma, medtech and innovative biotech. My projects focus on working together with the teams to solve current challenges, help them differentiate and plan effectively ahead of competitive or industry-wide events. 

What is your specialist expertise, and what types of projects do you work on?

I work across a range of CI monitoring, competitive benchmarking and workshops, and specialise in projects related to corporate strategy (cross portfolio, transformation, portfolio development), Market Access, clinical trial design (novel designs, accelerated or platform trials) and non-clinical differentiation (medical affairs, beyond-the-pill offering).

What did you do before Eradigm?

Before joining Eradigm and following my PhD, I completed a short Post-doc at the University of Cambridge, while in parallel building on my business acumen and consulting skills by contributing to various Consulting societies and attending Cambridge Judge Business School events.

What are your passions outside of work?

Outside of work you will likely find me hiking, playing/watching basketball or tennis, or reading a good book! I am generally passionate about all things innovation, learning about start ups and companies’ journeys and always on the hunt to add to my podcast list! 

Manager

Ilaria Coppola

Focus Therapy Areas: Oncology, Haematology, Neuroimmunology, Cardiovascular

Specialist Expertise: Cell & Gene Therapy, Rare Diseases, Digital Health

Education: BSc Biotechnology with a Year in Research, Imperial College London (First Class); MPhil Bioscience Enterprise University of Cambridge

What is your focus at Eradigm?

My focus is delivering high impact strategic insights at brand-level through peri-launch and post-launch Competitive Intelligence work, which includes attendance to leading therapy area conferences. My primary objective is providing value to the client with a meaningful so what? to ensure our contribution truly serves to identify future directions and tangible next steps.

Who do you work with?

My clients mainly include global CI managers, global and affiliate brand teams as well as senior strategic leaders across the top 15 biopharmaceuticals companies. On several occasions, my work has also exposed me to senior executive members from those organisations.

What is your specialist expertise, and what types of projects do you work on?

During my time at Eradigm, I have specialised in understanding the scientific and commercial value of cell & gene therapy (autologous, allogeneic), digital healthcare (digital therapeutics, screening algorithms) and rare neuroimmunological diseases. Within these fields, I have worked in CI monitoring projects, global technology landscaping and strategic workshop facilitation.

What did you do before Eradigm?

Before joining Eradigm, I interned in the Business Development Operations division at AstraZeneca, where I researched the regulatory and pricing interdependencies between European and International markets. 

What are your passions outside of work?

I am deeply curious about pretty much everything that happens around me, be it international politics, pop Instagram culture or a new restaurant that just opened down the road. However, my favourite ways of tetrising my free time include urban exploration, dinner hosting, swimming and 70s Italian thriller movies.

Senior Consultant

David McBay

Focus Therapy Areas: Oncology, Haematology, Immunology

Specialist Expertise: Cell & Gene Therapies, Digital Therapeutics, Value-Based Healthcare

Education: PhD Institute of Cancer Research; MSci Genetics University College London

What is your focus at Eradigm?

My focus is on delivering the highest quality of personalised, impactful research and insights that align with our client’s priorities to drive significant impact in Competitive Intelligence and Market Access. I work more often in clinically-focussed Competitive Intelligence, particularly to inform cell & gene therapy strategy.

Who do you work with?

I work with global Market Access, Competitive & Market Intelligence & Brand team leads across top 10 biopharma companies, in addition to cell and gene therapy focussed biotech. I have also recently worked with senior biopharma leadership on broader corporate strategy.

What is your specialist expertise, and what types of projects do you work on?

Global CI, particularly in the US for oncology and immunology; Global Market Access for cell and gene therapies; ‘beyond the pill’ commercial strategy and digital therapeutic corporate strategy are personal areas of expertise.

What did you do before Eradigm?

Before joining Eradigm, I undertook a PhD in DNA Damage Repair & Radiotherapy at the ICR, a particularly unique university given its biopharma industry partnerships and translational focus. I complimented my scientific studies by gaining commercial exposure through direct involvement on the ICR’s Board of Trustees. 

What are your passions outside of work?

Outside of work, I’m passionate about a five-a-side kayaking team sport called ‘Canoe Polo’, competing at an international level, including the CPSL Super League. I also have a love for conservation and travelling that I combine through amateur wildlife photography.

Senior Consultant

Nathanael Green

Focus Therapy Areas: Oncology, Haematology, Immunology

Specialist Expertise: Cell & Gene Therapy, Pricing Strategy, Market Access and Personalised Medicine

Education: BSc Biochemistry, Cardiff University (Upper Second Class); MSc Drug Development Sciences, King’s College London (Distinction)

What is your focus at Eradigm?

To drive forward my passion for deciphering the true value of innovative healthcare products to provide strategic insights and solutions for impactful Market Access launch strategies. Working across a wide range of asset-level and Corporate Strategy projects, and Global Competitive Intelligence Monitoring, my aim is to deliver top-tier impactful recommendations and strategies to drive success for our clients.

Who do you work with?

I predominately work with global franchise teams, Market Access and commercial strategy leaders and senior leadership teams of top 15 biopharmaceutical and biotech companies.

What is your specialist expertise, and what types of projects do you work on?

My expertise lies within Cell & Gene Therapies and Market Access Excellence. My project portfolio has focused on several key areas, including cell & gene therapies (launch excellence, manufacturing and commercial strategy), pricing strategies (pre-launch and LOE), CI monitoring and Market Access Strategy & Access.

What did you do before Eradigm?

Before joining Eradigm, I gained Market Access experience as part of the Life Sciences Strategy & Access team at BearingPoint, where I contributed to several projects focusing on topics ranging from oncology to AI in healthcare. Prior to this, I presented my dissertation research on the Pharmacoeconomics and Market Access of Orphan Drugs as a finalist at the ISPOR 2019 conference.

What are your passions outside of work?

Outside of work, I enjoy long distance running, having completed numerous half and full marathons, and am a keen skier. I am also a passionate cook and love a wide range of music.

Consultant

On Yee Wong

Focus Therapy Areas: Oncology, Rare Disease, Cardiovascular

Specialist Expertise: Pricing and Market Access Strategy, Landscape Assessments, Value-based Healthcare

Education: BSc Biomedical Science, Royal Holloway University of London; MPH Public Health, Imperial College London

What is your focus at Eradigm?

To drive forward my passion for improving patients’ lives through informing healthcare decisions and optimising market access outcomes. My focus is on delivering meaningful and actionable insights and recommendations through high quality research tailored for our clients.

Who do you work with?

I typically collaborate with global franchise teams and access strategy leaders, from both Big Pharma and small to mid-size Biotech companies.

What is your specialist expertise, and what types of projects do you work on?

My expertise lies in achieving market access excellence through understanding various pricing and reimbursement challenges and developing strategic solutions to address business needs across broad therapeutic areas and geographical regions. Key capabilities include global primary research experience with payers and stakeholders, as well as secondary research synthesis, such as landscape assessments to support evidence gap analysis and planning for clients.

What did you do before Eradigm?

Prior to Eradigm, I worked for 5+ years at global healthcare value and market access strategy consulting firms. I have gained experience across a variety of HEOR and market access work, including HTA landscaping, primary payer research, systematic literature reviews, health economic modelling, payer value proposition, objection handlers, and external publications. 

What are your passions outside of work?

One of my passions is photography. I love capturing moments and expressing myself creatively through the lens. Outside of work, I enjoy going to the gym, watching films, travelling, and trying out new restaurants.

Senior Consultant

Flavia Fioretti

Focus Therapy Areas: Oncology, Immunology/Rheumatology, Vaccines, Rare Diseases

Specialist Expertise: Competitor strategy, lifecycle management, clinical trial design, manufacturing and supply chain analysis, Cell & Gene Therapy, ADC, Biosimilars

Education: MSc Molecular Biology, University “Federico II” of Naples; MRes in Cancer Biology, Imperial College London; Ph.D. in Oncology Drug Development, Imperial College London

What is your focus at Eradigm?

At Eradigm, I bring deep scientific expertise, and clinical and commercial insights to answer our clients’ critical questions both on Strategy and Global Competitive Intelligence projects, always striving for a meaningful and collaborative approach in every engagement.

Who do you work with?

I work with global commercial and intelligence leads from Top 10 Pharma companies and small to mid-sized biotechs, bridging the gap between different teams and supporting decision-making at a product, franchise, and corporate level.

What is your specialist expertise, and what types of projects do you work on?

I have deep expertise in oncology (solid and heme), precision medicine, and next-generation diagnostics. However, I have worked on a broad range of engagements across a range of therapy areas and geographies, including product lifecycle management and long-term global CI monitoring.

What did you do before Eradigm?

Before joining Eradigm, I spent 4 years at another consulting firm in the UK leading multiple competitive strategy engagements supporting the development and commercialisation of several assets. Before consulting, I worked as a clinical project manager in early-phase clinical trials where I acquired in-depth expertise on clinical trial design and the regulatory landscape for drug approval.

What are your passions outside of work?

Outside of work, I rest and relax by practicing yoga and spinning, buying plants, immersing myself in a good book, visiting museums and exhibitions, or going on long car drives to sing songs from the noughties very loudly.

Senior Consultant

Antoine Coum

Focus Therapy Areas: Oncology, Neuroscience, Cardiovascular, Infectious Diseases

Specialist Expertise: Patient Services, Competitive Benchmarking, Market Access

Education: MSc Biochemical Engineering Ecole Nationale Supérieure de Chimie de Montpellier, MSc Cancer Biology Université de Montpellier II, PhD Developmental Neurobiology King’s College London

What is your focus at Eradigm?

I provide valuable, strategic insights through the synthesis of information from highly relevant secondary research resources and conduct of interviews with first-class leading subject-matter experts, and aim to garner and contribute pioneering recommendations impactful for clients and patients alike.  

Who do you work with?

I partner with a range of stakeholders, including commercial and global brand teams, from both Big Pharma and mid-sized companies. I actively look to work alongside innovative oncology and healthcare technology organisations to promote a patient-centric approach to health and care globally.

What is your specialist expertise, and what types of projects do you work on?

I have a holistic understanding of the healthcare paradigm, from pre-clinical innovation to product life cycle management, as well as a swiss-army knife knowledge of several therapeutic areas. My rapidly growing project experience includes Global Competitive Intelligence monitoring of infectious diseases, strategic assessment of innovative patient services in rare diseases, and assessment of payer value perception of patient services in Haematology Market Access .

What did you do before Eradigm?

Before joining Eradigm, I developed BD and deep industry expertise while working at the Gerson Lehrman Group, partnering with senior executives of pharmaceutical and healthcare technology companies to engage with subject-matter experts.

What are your passions outside of work?

My main interest outside of work revolves around fitness and wellbeing through the practice of basketball and swimming, as well as any physical activity accessible. I balance over-exercising by immersing myself in physical books, with a soft spot for poetry.

Senior Consultant Commercial Excellence Lead (Advisory BU)

Erin Johnstone

Focus areas: Oncology, Dermatology, Ophthalmology, Neurology and Rare Disease

Specialist expertise: Rare Disease, Personalized Medicine, Omnichannel Strategy, Competitor Strategy, Commercial Strategy, Forecasting and Market Access

Education: MSci Chemistry with Medicinal Chemistry, University of Glasgow

What is your focus at Eradigm?

My focus at Eradigm is to be the trusted thought partner to all clients, and the Eradigm team, to deliver winning commercial and market access recommendations; driving patient and HCP centricity in all future client discussions and strategies.

Who do you work with?

Global top 50 pharmaceutical companies as well as leading biotechnology companies from IPO and beyond. I have supported a variety of teams across global, regional and local regions spanning marketing, brand, new product planning and market access roles.

What is your specialist expertise, and what types of projects do you work on?

I have broad expertise in Commercial Strategy. I enjoy solving client complex challenges from planning for a competitive launch through to enhancing a first-to-market ground-breaking launch. Key project areas include: commercial forecast development, patient pathway creation, scenario planning, competitor strategy, omnichannel strategy and, global launch readiness guidebooks. 

What did you do before Eradigm?

Before joining Eradigm, I worked for 6+ years at market access as well as strategic consulting firms who focussed exclusively on healthcare. I also gained experience in business development and grant applications for science and technology. 

What are your passions outside of work? 

Outside of work my main passion is travel, with almost any spare minute used to plan, or go on, my next adventure. I love to explore the outdoors, walk a new trail, and discover a new mountain to ski on. When I am not travelling, I enjoy a games night with great food, family, friends and dog.

Senior Consultant

Maria Delgado

Maria joined Eradigm in May 2021 as an Associate Consultant, bringing to the team her passion for the pharmaceutical industry and her two-year consulting experience. Her previous consulting role spanned multiple therapeutic areas including oncology, neurology, immunology and rare diseases through competitive intelligence as well as market research/access projects of global scope. Through these projects, she acted as a strategic thought partner to some of the key pharmaceutical players providing real-time support in the development and commercialisation of life-saving medicines from early-stage to the post-marketing phase.

She holds a PhD In Synthetic/Molecular Biology from the University of East Anglia, funded by the Eastern Academic Research Consortium, focused on understanding calcium signal decoding. Further research experience includes a one-year research project in Synthetic Biology at Cardiff University through the Erasmus+ international mobility program. During her time in academia, she attended national and international conferences and events where she had the opportunity to present her research to wide audiences.

Prior to academia and during her studies, she participated in voluntary work including food and toy collection for the less fortunate as well as worked as a Medical Laboratory Assistant for the NHS. Both experiences stimulated her desire to make a difference to the lives of others, contributing to her passion for making an impact in society through the pharmaceutical industry.

Outside of work, Maria considers herself a “foodie”. She is a passionate cook and baker and loves discovering new cultures through their cuisine. She also enjoys fitness and is a dance enthusiast, particularly for Latin dances such as salsa and bachata.

Senior Consultant

Brynna Hoggard

Brynna joined Eradigm in July 2021 as an Associate Consultant, bringing extensive experience in biomedical research and a passion for global healthcare.

She holds a PhD in Cancer Biology from Barts Cancer Institute in London, part of Barts and the London School of Medicine and Dentistry. Her research was funded by the Biotechnology and Biological Sciences Research Council and focused on using technology to answer biological questions. There she was part of a multidisciplinary team of biologists and engineers, working to characterise and target a newly identified lung cancer driver mutation, and identify novel therapeutic strategies to treat it.

After completing her PhD, Brynna was awarded a grant to continue her research at Barts Cancer Institute as a postdoctoral researcher, and begin translating her research in the clinical sphere.

Prior to her academic studies, Brynna also worked in global health, where she developed tailored solutions to meet the needs of rural communities in Madagascar. There she led an initiative to improve public and environmental health through sustainable economic growth.

Outside of work, Brynna loves trying new and delicious food, as long as she doesn’t have to do the cooking. She is also an avid reader, loves taking on new knitting projects, and is learning to play the piano.

Senior Associate Consultant

Jai Bhakta

Jai joined Eradigm in April 2022 as a Senior Associate Consultant. Jai found himself joining the Eradigm team with his goal of advancing transformative therapies and technologies to patients and stakeholders across the healthcare and life sciences industries. Jai’s experience harmonizes breakthrough academic and commercial knowledge working across different sectors within the life sciences and healthcare industries. His knowledge spans across a variety of therapeutic areas and has expertise in medical devices and diagnostics.

Jai holds a Bachelor of Science and Arts from the University of Texas, where he was given the opportunity as a Research Assistant at the UT Clinical Neuroendocrinology Laboratory, receiving authorship on a late breaking abstract titled “Basal Salivary Testosterone Predicts Trait Anxiety in Healthy Men and Women”. His curiosity for advancing breakthrough research led him to Claremont College’s Keck Graduate Institute, where he received his Master of Business and Science with a concentration in Medical Devices and Diagnostics. At his time at Keck Graduate Institute, Jai served as a Graduate Student Consultant in Product Development for Nanosens Innovations, where he engaged in creating robust product profiles for NanoSens’ graphene-based dCas9-functionalized biosensor. Prior to completing his studies, Jai interned on City of Hope’s Research Business Development team. His time at City of Hope exposed him to internal development efforts, creative due diligence, out-licensing strategy, competitive intelligence, valuation, and City of Hope’s internal venture panels.

Prior to his role at Eradigm, Jai conducted global competitive intelligence at Decisive, partnering with top 20 Big Pharma companies spanning across therapeutic areas such as Oncology, Dermatology, Women’s Health, and Rare Diseases. He provided expansive due diligence and primary research analysis to B-Suite and C-Suite level executive teams.

 In his free time Jai likes to spend time with family and friends, draw, paint, produce & listen to music, cook a variety of cuisines, weight-train, and watch basketball and football (NCAA and Professional). 

Senior Associate Consultant

Michelle Saylor

Focus Therapy Area: Oncology, Neurodegenerative Diseases, Ophthalmology

Specialist Expertise: Diagnostics, Precision Medicine, Coverage and Reimbursement  

Education: Bachelor of Science from Brandeis University, with a concentration in Biology

What is your focus at Eradigm: My focus area at Eradigm is primarily market access which consists of elements that include commercial strategy and competitor and historic analysis. I work with a variety of stakeholders, industry giants to start-ups, that span across therapeutic areas.

What is your specialist expertise and what types of projects do you work on? I have both breadth and depth experience in multiple therapeutic areas that span from orphan drugs and rare diseases to more common spaces such as cancers and cardiovascular events. I assess market readiness through extensive research and perform additional analyses based on pricing, current coverage landscapes and competitive intelligence. Regardless of business questions or disease space, I always aim to deliver high-quality and solution-oriented work.

What did you do before Eradigm? Prior to Eradigm, I worked for a boutique healthcare consulting firm in Boston, MA. There, my focus was primarily commercial strategy, market access, and pricing and reimbursement.

What are your passions outside of work? I love all things having to do with food: cooking, eating, tasting, and enjoying meals with friends and family. I travel quite a bit and am working my way down my ever-expanding list of places to see. When I’m not travelling or munching, I like to read, watch documentaries, and play with my dogs.

Consultant

Aaron Sunil

Specialist Expertise: Customer Experience, Patient Services, Patient Journey Mapping, Digital Landscaping

Education: B.A. in Biology, with a minor in Neuroscience from Wake Forest University, M.S. in Clinical Research, with a focus in Translational Oncology from the Icahn School of Medicine at Mount Sinai

What is your focus at Eradigm?
Throughout my professional background, I’ve brought to the table simplified and impactful solutions to holistically address needs across Patient Services, Market Access, and Benchmarking teams/projects. My passion, drive, and perseverance have allowed me to engage in meaningful partnerships with client teams, define solutions, and achieve goals.

Who do you work with?
I’ve worked predominantly with domestic team leads and directors for patient services, market access, marketing, and analytics – that head top 10 biopharmaceutical companies. Through previous partnerships, I’ve assisted brands to create, implement, and optimize their customer experience strategies – for therapies/products in market and soon to launch.

What is your specialist expertise, and what types of projects do you work on?
I have both broad commercial experience and specialist expertise, including CAR-T therapies, customer experience, and market access projects. My extensive portfolio of projects includes domestic CAR-T patient journey mapping, recommending a buildout of specific patient support programs for a soon-to-launch drug, and conducting a wholescale review of a patient services team to identify areas of opportunity leading to the creation of a strategic roadmap.

What did you do before Eradigm?
Prior to Eradigm, I rose through the ranks at a boutique consulting firm in the greater NYC area. While there, my areas of focus were generally commercial market analysis, digital landscaping, recommending patient services solutions, and acting as a thought partner to Top-10 pharmaceutical brand team leads. Before consulting, I conducted research for the Mount Sinai BioDesign Team, helping to design and implement novel solutions for neurological and cardiovascular patient issues.

What are your passions outside of work?
For starters, I love listening to and discovering music! I try to listen to wide variety of genres, usually when doing some of my other hobbies, such as weight-lifting, playing basketball, or hiking. On the weekends, I can usually be found watching an Arsenal match with friends or reading on the Hudson.

Senior Associate Consultant

Cooper Grayson

Cooper holds a bachelor’s degree in Biology, Health and Society from the University of Michigan, with a focus in public health, and the ethics of health and medicine. During his studies, he also minored in the Sociology of Health and Medicine and also participated in various student organizations including the Health Policy Student Association and the Pre-Public Health Association.  

Together, this has added to Cooper’s interests in the multitude of aspects within pharma and healthcare that go into changing the lives of patients for the better, who has found consulting as a method to gain knowledge and experience in these unique spaces. 

As part of his career and prior to Eradigm, Cooper spent time working with a Top10 pharmaceutical company functioning as a project manager on a handful of their global medical teams, most recently in the area of immuno-oncology GI & liver cancer. Cooper has gained experience and expertise in pharmaceutical project management, launch planning & development, secondary research and market access. Cooper has also had hands-on experience providing secondary research for a biotech company specializing in leveraging proprietary computational systems like A.I., to accelerate the development of novel drug alternatives for life threatening diseases.

Outside of work, Cooper is an avid sports fan, with his favorite teams being the New York Mets, Jets, Rangers, Brooklyn Nets, Tottenham Hotspur, and all University of Michigan athletic teams. Cooper also enjoys standup comedy and is a true seeker of new cuisines. In his free time, Cooper likes to explore his home of New York City, exercise / play sports, listen to music, and discover new restaurants. 

Senior Associate Consultant

Hisham Nachabe

Hisham joined Eradigm in June 2022 as a senior associate consultant. He brings to Eradigm a breadth of scientific and consulting experience having completed an ORISE research fellowship at the Walter Reed Institute of Army Research, before channelling his interest in life sciences and enthusiasm for pharma into market access strategy and financial analysis.

With a BSc in Biology and Biotechnology Hisham has a passion for breakthrough science and emerging therapeutics. He has combined this passion with robust secondary research to generate impactful strategy solutions for various clients around the globe. At Eradigm, Hisham’s goal is to help develop a roadmap of success, built on market research, primary engagement, and a deep understanding of financial models. Strong communication is a cornerstone of Hisham’s approach, with contributions to a number of published papers and reports, he enjoys building relationships with Key Opinion leaders to providecritical perspectives that shape his work. His previous projects have spanned various therapeutic areas with his expertise focusing on oncology, neurology, medical devices, and public health.

Outside of work, Hasham loves personal fitness with a particular interest in weight training. He also enjoys outdoor pursuits such as tennis, hiking, kayaking, and camping at the weekends (when the weather permits). In his downtime, Hisham’s a keen reader with a distinct interest in philosophy.

Consultant

Zunaira Mallick

Zunaira joined Eradigm in March 2022 as an Associate Consultant. With a passion to increase healthcare accessibility, she brings extensive academic and commercial experience from working globally across both public and private healthcare spaces.  

Zunaira has previously delivered competitive market strategy projects spanning multiple disease areas including gastroenterology, haematology, immunology, psychiatry, and rare diseases. Having worked at a health strategy firm with global, EU and UK product teams for the top 20 pharma companies, she has developed expertise in liaising with key stakeholders to identify areas of growth across the entire drug lifecycle, from pre-clinical development to go-to-market (GMT) strategies for new entrants including CAR-T therapy in multiple myeloma. In addition, she has extensively conducted primary and secondary research to monitor and assess competitive landscapes in cell and antibody-based therapies within the wider pharmaceutical industry. She has also worked with regulatory bodies and pharma product managers on developing health technology assessment (HTA) strategies for a medical device used to treat depression, with a focus towards evaluating patient-centric, value-driven evidence. 

Prior to this, Zunaira has conducted comprehensive research in the public healthcare sector, first as a policy analyst developing tactical recommendations on improving patient access to primary care medical facilities in South Asia, followed by her work leading educational workshops for a global rheumatic heart disease clinical trial. 

Zunaira completed her MSc from the University of Oxford in Integrated Immunology, graduating top three in her year. Her thesis was focused on developing a Point-of-Care (PoC) diagnostic test for immune profiling sepsis patients in intensive care settings. In this project, she successfully used host transcriptomics data to identify differentially expressed genes for subgrouping patients and was then able to develop a PCR-based technique for testing patient samples which proved to be 99.1% diagnostically accurate. As part of the project, she also comprehensively conducted due diligence on different sequencing technologies for the purpose of setting up a commercial diagnostic test. This test was later used to effectively immune profile septic COVID-19 patients as part of the extended research study at the Wellcome Trust for Human Genetics. 

Zunaira holds a BSc (Honours) in Biomedical Sciences from the University of Waterloo, where she graduated Summa Cum Laude and was one of seven students in the entire Faculty of Science to win the National Science and Engineering Research Council (NSERC) Award for excellence in research focusing on characterising a novel bacterium. 

In her spare time, Zunaira likes to brainstorm ideas for AI-enabled initiatives that are aimed at improving patient care pathways. She also likes to read historical non-fiction and poetry. In addition, she is an avid art (poster) collector, always on the hunt for exhibitions featuring surrealist, abstract expressionist, and post-impressionist artworks. In sports, she enjoys playing badminton and tennis, and has previously swam and rowed competitively in school and at university respectively.

Senior Associate Consultant

Sneha Chatterjee

Sneha joined Eradigm in April 2022 as an Associate Consultant, bringing to the team her experience in infectious diseases research and a strive for contributing to global healthcare enhancement.

Sneha worked in consulting projects spanning therapeutic areas such as oncology, infectious diseases, haematology and rare diseases, and devices. She was involved in conducting competitive intelligence for multiple projects delivered on market assessment, data analytics, KOL profiling and social media analytics geographies including US, EU, LATAM and APAC markets. She was responsible for project management and driving multiple strategic intelligence engagements for year-long tracker projects to help clients understand and strategize their competition. She has also gained profound experience in collecting comprehensive market, competitor and stakeholder evidence through desk-based interviewing and elicitation; conducting research and analysing industry trends and data, create competitive landscape to understand the healthcare scenario, and comprehend reimbursement policies in global pharmaceutical market.

By qualification, Sneha is a medical microbiologist and obtained her PhD in infectious diseases with her research in the in overlapping fields of immunology and host-pathogen interaction, from the Medical University of Innsbruck, Austria. Her thesis decoded the role of Shiga toxin produced by Enterohemorrhagic E. coli (EHEC) in Haemolytic Uremic Syndrome (HUS). Prior to that, she secured her masters in Applied Microbiology from the VIT University, India, and bachelors in Microbiology (Honours) from the University of Delhi, India.

Outside of work, Sneha loves to travel and enjoys being acquainted with new cultures and trends. She loves to sing and has also lent her voice to a few short films as a playback singer. She is also trained in Indian dance forms, which she feels keeps her connected to her roots. Sneha loves to try out new cuisines and try her hands at cooking every once in a while.

Sneha believes in the idea of translational research with direct bench-to-bedside significance, and with her cumulative experience, would like to contribute to create a positive impact in the global healthcare space.

Consultant

YanWen Chong

YanWen brings with her a breadth of healthcare, research, and management consulting experience as she joins Eradigm in April 2022. Her previous professional experience includes strategy and operations consulting in PricewaterhouseCoopers as well as drug re-purposing research in a joint Masters’ project between UCL and Hanyang University of South Korea. Her previous consulting experience includes delivering and supporting work in:

Pharmaceutical & Life Sciences: Cost-to-serve, customer service models, market access, regulatory and reimbursement, digital operations, and commercialisation strategies with global PharmaCos and Medtech clients.

Healthcare: Strategy development, strategic option appraisals, benefits costing, operating model design, and system level sustainability plan development with NHS Trusts and Integrated Care Boards.

In building a cross-functional, broad therapeutic portfolio and having a strong person-centric health and care foundation, YanWen hopes to deliver meaningful strategic insights and recommendations that will make a difference.

Outside of work, YanWen loves being active and exploring the city by foot, being a wannabe foodie, and planning her next adventure. Her curiosity in all things DIY and love for socialising means lots of crafty projects (they make for cozy events – pumpkin carving? wreath making? #yes). And of course, she enjoys a good pint or a cheeky cocktail while engaging in conversations about the meaning of life!

Consultant

Jeanne-Claire Vincent

Focus Therapy Areas: Oncology (Solid Tumors & Hematology), Rare Disease, Cardiovascular

Specialist Expertise: Pricing and Market Access Strategy, Landscape Assessments, Market Insights

Education: BEng Mechanical Engineering, McGill University; MScEng Biomedical Engineering, Imperial College London

What is your focus at Eradigm?

At Eradigm, I bring a strong analytical background and understanding of global strategy, access, and pricing dynamics. My focus delivering targeted and impactful insights and recommendations to clients through high quality research and a collaborative engagement approach

Who do you work with?

I typically collaborate with global commercial and access teams, from both top 10-pharma and small to mid-size biotech companies.

What is your specialist expertise, and what types of projects do you work on?

My expertise lies in achieving developing strategic solutions to address business needs across broad therapeutic areas and geographical regions. I work across different project types delivering impactful market insights, commercial strategy recommendations, and understanding various pricing and reimbursement challenges in key geographies including the EU and Japan. Key capabilities include global primary research experience with payers and stakeholders, as well as secondaryresearch based landscape mapping in oncology, giving strategic support to clients across the product development lifecycle

What did you do before Eradigm?

Prior to Eradigm, I completed my MScEng degree in Biomedical Engineering completing a year-long research project working with a multidisciplinary team of doctors and engineers to build computational models that simulate and predict the development of congenital heart diseases in fetuses

What are your passions outside of work?

Outside of studies and work, I participated in several medical mission trips to rural and underserved communities in Haiti, Jamaica, India, and Brazil; experiences which have given me the motivation to make an impact on society through the biopharma industry. In my spare time, I love to travel, read and watch old movies

Senior Associate Consultant

Barney Poznansky

Barney joined Eradigm in January 2022 as an Associate Consultant, bringing an experience in bioscience research and a passion for improving global healthcare.

He holds a PhD in Interdisciplinary Bioscience from the University of Oxford, which formed part of a Doctoral Training Programme funded by the Biotechnology and Biological Sciences Research Council. Barney’s work focused on combining biocatalysts with continuous flow technology to improve the sustainable synthesis of pharmaceutical compounds. He was part of a team of chemists, biologists and engineers who worked to develop this biotechnology and successfully spin-out a company. In recognition of his work on this project, Barney was awarded a commendation in Enterprise and Innovation at the University of Oxford Bioscience Impact Awards.

As part of his PhD, Barney undertook a work placement at a large generics company. As part of the team, Barney applied the processes that he had developed in the academic laboratory to industrially relevant chemical transformations.  

Barney completed his formative academic studies at the University of Warwick, graduating with an MChem in Chemistry with Professional Experience. His dissertation focused on performing enantioselective synthesis using novel organocatalysts. During his third year of study, Barney undertook a four-month placement at Monash University, Australia, which ignited his passion for academic research. 

Outside of his work, Barney is a keen sportsman, who has played football at university level. He continues to enjoy many other sports, including cricket, golf, and squash, and finds pleasure in cooking, having a particular love for Indian and Italian cuisine. An inherited passion for music took hold during his younger years, growing up in Cornwall, at which time he travelled with local orchestras to perform in locations as far afield as San Francisco.

Senior Associate Consultant

Emer Murphy

Emer contributes deep scientific expertise to the Eradigm team, where in her prior role she worked as a scientist on early-stage drug discovery projects with the CRUK-Astra Zeneca drug discovery alliance. This work included strategic planning of accelerated projects, managing external collaborations, and identifying new potential targets for immunooncology assets. 

Emer’s has a BSc. in Human Genetics from University College Cork, Ireland, where her focus aimed to identify the heritability of Psychosis disorders. Following this, she went on to complete an MSc. in Molecular Medicine from the University of Leeds. In her Master’s research, Emer investigated the effect of a novel small molecule inhibitor in comparison to, and in combination with, standard of care chemotherapy in childhood Ewing’s Sarcoma on primary samples from St James University Hospital in Leeds. 

Outside of work, Emer enjoys cooking, writing her food blog, making her way through the best restaurants in London and running in Victoria Park to counteract all of that. Emer enjoys reading Scandi Noir novels, while trying to keep her houseplants alive.  

Senior Associate Consultant

Guglielmo Bruni Roccia

Guglielmo joined Eradigm in February 2022 as an Associate Consultant, bringing to the team his curiosity for the life sciences and passion for global healthcare.

In his previous role, Guglielmo worked in consulting projects spanning therapeutic areas including oncology, rare diseases, and women’s health. He was involved in advising clients with their growth strategy, by identifying assets for potential acquisition to expand their drug portfolio. Guglielmo also focused on competitive intelligence (CI) projects, where he monitored competitor’s clinical trial developments, product launch timelines and marketing strategies, to help clients, understand their competitive environment and the opportunities and challenges it presents. He also gained relevant experience while working for the Luxembourg Institute of Health where he was part of a team developing a drug monitoring device for patients with chronic conditions. 

Guglielmo studied for an MSc in Drug Discovery and Pharma Management at University College London (UCL), where he gained a holistic understanding of the regulatory and commercial aspects of drug development. His master’s thesis focused on the unmet needs of in vitro fertilisation and the emerging innovative solutions. He holds a BSc in Neuroscience from the University of Sussex with an integrated exchange academic year at the Nanyang Technological University in Singapore. 

In his free time, Guglielmo is an avid runner and tennis player. He also fosters a deep enthusiasm for classical music, having been playing the violin since he was 6 years old. Passionate about exploring new cultures, Guglielmo enjoys travelling around the world, meeting new people, and experiencing local cuisines.

Senior Associate Consultant

Jada Mejia

Jada joined Eradigm in March 2022 as an Associate Consultant. She brings extensive pharmaceutical market research experience and a passion for global healthcare. In her previous role, she focused on primary and secondary quantitative research, designing surveys aimed at HCPs and consumers whilst also creating client deliverables that answer their main research objectives. 

Jada holds a Bsc. in Health Sciences with a specialisation in Policy, Management and Evaluation of Healthcare from Maastricht University in the Netherlands. During her Bsc. Jada did a 6-month exchange programme at McMaster University in Canada, where she further developed her global healthcare knowledge by undertaking several Canadian healthcare courses. Jada’s curiosity and passion to help improve healthcare systems led her to pursue an Msc. degree in Health Economics, Policy and Law at Erasmus University in Rotterdam, the Netherlands. For her final research project Jada conducted a quantitative survey focussing on whether healthcare rationing occurs amongst GPs in Aruba. 

Being born and raised in Aruba before moving to the Netherlands at 18, Jada has been fortunate enough to explore a variety of different cultures and languages. Jada is fluent in Dutch, Papiamento and English, has intermediate level Spanish and is keen to learn British Sign Language. Prior to academia, Jada formed part of the Aruban Taekwondo National Team, competing in different national and international championships. Outside of work, Jada enjoys going to the gym, watching films, singing and hanging out with friends. 

Associate Consultant

Shreya Murali

Shreya joined Eradigm in April 2021 as an associate consultant. With a keen interest in novel therapeutic strategies, Shreya brings her experience in biomedical research and knowledge of the pharmaceutical industry to the team.

Shreya achieved her Master’s in Novel Therapies- Genes, Drugs and Stem Cells at Imperial College London where she took a multidisciplinary approach to understanding gene therapies, regenerative medicine, and the drug development process. For her master’s thesis, she worked on the optimization of synthetic mRNA for therapeutic use in airway epithelial cells. Prior to this, she completed her Bachelor’s degree in Genetics from the University of Sussex where she carried out research investigating the relationship between the structure and stability of DNA replication checkpoint proteins.

Alongside her academics, Shreya worked on an investment management start-up specializing in digital assets. This venture stimulated her ambition to apply her experience in life sciences in a more strategic business environment. She is also a huge believer in increasing the accessibility of education and has spent a year as a volunteer teacher, tutoring underprivileged kids in shelter homes in mathematics and science.

In her free time, Shreya enjoys exploring new restaurants, going to the cinema, and hiking. She summited Mt Kilimanjaro in 2018 to fundraise for clean water and sanitation and aims to summit Mt Everest by 2026.

Senior Associate Consultant

Oliver Odell

Oliver holds a PhD in Nutrition and Human Metabolism from the University of Birmingham, which was part of a Doctoral Training Programme funded by the Biotechnology and Biological Sciences Research Council. Oliver’s work focused on dairy nutrition, specifically trying to understand the metabolism of the milk sugar lactose in humans, to try to identify new applications for this low value, side stream product of the dairy industry. He has run human volunteer studies, in university laboratory and hospital settings across the country. He is interested in the intersection of nutrition and other modifiable lifestyle factors and healthcare, as well as life sciences and health more broadly.

Oliver also spent time working with the industrial partner of his PhD, a major European dairy ingredients company. He ran a market research project into consumer habits to identify gaps in product offerings and nominate new ingredients and products for development. This built on his previous experience in market research, throughout his undergraduate degree at the University of Exeter. Throughout his PhD, Oliver taught undergraduates extensively, from lecturing to running laboratory sessions. He particularly enjoyed the process of breaking down complex topics and explaining them to students. He is also an Associate Fellow of the Higher Education Academy.

Oliver is a passionate scuba diver, having recently completed his rescue diver qualification, he has dived extensively in Europe, Asia and Africa. Oliver is also a competitive powerlifter in his free time though has a keen interest in other strength sports. Throughout 2021 he volunteered with St John Ambulance to assist with the vaccine rollout, administering vaccines and helping to organise the day to day running vaccine centres.

Senior Associate Consultant

Nadeen Solaiman

Nadeen joined Eradigm in April 2022 as an Associate Consultant, bringing to the team her extensive experience in genetic engineering and cancer research, and everlasting passion for the Life Sciences industry.

Nadeen holds a PhD in Molecular Biology & Biochemistry from the University of Westminster, where her work focused on the molecular characterisation a novel cancer driver gene in replication stress-induced genomic instability using CRISPR/Cas-based human cellular models, in collaboration with the Francis Crick Institute and the University of Zurich. During the pursuit of her doctorate, Nadeen was awarded research grants to support the clinical translation of genetically-engineered human cellular models to commercial products, in collaboration with renowned Life Science industries. Nadeen was also heavily involved in the co-design and mentorship of IBMS-accredited CRISPR/Cas-based workshops where she was consulted for her technical expertise on the use and applications of the cutting-edge technology.

Alongside her PhD studies, Nadeen acquired a professional development qualification in learning and teaching within the Higher Education Academy, U.K., and held a Visiting Lectureship position in Life Sciences at the University of Westminster for over three years. She also has experience in working as a Molecular Biologist at Health Services Laboratories (HSL) where she acquired extensive knowledge on the evolving clinical diagnostic landscape.

Outside of work, Nadeen is a curious soul who enjoys meeting new people and visiting new places. In her spare time, Nadeen enjoys salsa dancing as well as fitness through the practice of kickboxing, running and Pilates. She also enjoys reading on Science-related subjects and self-development, and whenever she gets the opportunity, she loves to travel and explore new cultures.  

Senior Associate Consultant

Paula Wegbrans Giro

Paula joined Eradigm in May 2022 as an Associate Consultant. With a keen interest in personalised medicine and novel therapies, Paula brings her experience in biomedical research to the team.

Paula holds an MSc in Engineering for Biomedicine from Imperial College London, where she researched new materials approaches for the detection and treatment of cancer. Prior to that, Paula completed her BSc in Human Biology from Pompeu Fabra University in Spain, where she took a multidisciplinary approach to learn about biomedical sciences and did her bachelor’s thesis on secretion pathways altered by colon cancer. During her BSc, Paula did an exchange programme at the Amsterdam University College in The Netherlands where she took global healthcare courses and developed her language skills.

Alongside her education, Paula spent time doing internships at the University of California San Diego, in the US, and at Sant Pau Hospital, in Spain, where she explored clinical and genetic approaches to diseases of the airways. These experiences in different cultures grew her ambition to use her life sciences knowledge for application approaches in an industry environment and led Paula to work on innovation strategies in between her studies.

Paula also believes in bringing scientific knowledge and education closer to those outside the science and medical communities and has worked and volunteered in Medical Information and Tutoring projects to increase accessibility in these areas.

Outside of work, Paula enjoys travelling, cooking, and music. She has a keen interest in combining these three hobbies and finding new ways of sharing them with other people. 

Senior Associate Consultant

Aalia Jawad

Focus Therapy Areas: Neurology, Rare Diseases, Infectious Diseases

Specialist Expertise: Pricing Strategy, Market Access Strategy, Landscape Assessments, Demand Forecasting, Payer Research, Country Prioritization, Launch Sequencing, and Market Research

Education: BSc (Hons) Biomedical Science, University of Edinburgh. Aalia holds a Lean Six Sigma Green Belt from the University of Oxford

What is your focus at Eradigm?

I use my analytical background and previous consulting experience to support biopharma companies solve their most fundamental challenges throughout the market access and ensure patients can access new treatments

Who do you work with?

I largely collaborate with commercial, value, and access teams and market research teams at Big Pharma and small to mid-size biotech companies

What is your specialist expertise, and what types of projects do you work on?

Aalia’s expertise spans Market Access Strategy, particularly in pricing analysis, demand forecasting, and launch sequencing using secondary research and payer interviews to inform strategic decision making

What did you do before Eradigm?

Prior to joining Eradigm, Aalia supported multiple projects in life sciences and across financial services and consumer goods across commercial strategy, organizational strategy and operating model design, process re-engineering and operational excellence, supply chain analysis, cost optimisation, and EBITDA improvement

What are your passions outside of work?

Outside of work, Aalia is an enthusiastic cook and enjoys experimenting with new flavours and cultures. In her spare time, you can find her exploring London’s newest restaurants, spending time with her family, and trying to keep her plants alive

Associate Consultant

Zain Aziz

Zain joined Eradigm in May 2022 as an Associate Consultant bringing to the team his curiosity for the life sciences and passion for global healthcare.

Prior to joining Eradigm, Zain has worked in consulting projects with different healthcare providers across Europe aiding in their digital transformation process and the implementation of electronic patient healthcare record systems. His focus was mainly within clinical research organisation, and he was heavily involved with advising clients as to how to identify potential opportunities to increase recruitment onto clinical studies, as well as increasing patient study visibility for trust members, with the end goal to provide better overall care for patients being treated.

Zain holds a BSc and PhD in Biomedical Sciences and Biotechnology, respectively from the University of Westminster. His research was focused on the development of novel fermentation strategies to increase the production of bioplastics through the manipulation bacterial communication circuits. During his PhD, Zain was also able to acquire a professional development qualification in learning and teaching within the
Higher Education Academy, U.K.

Outside of work, Zain is an avid hiker and frequent gym-goer who loves to travel and visit new places. In his free time, he enjoys exploring London’s live music offerings and carrying out DIY projects.

Senior Associate Consultant

Kelly Choong

Kelly joined Eradigm in June 2022 as an Associate Consultant, bringing to the team her experience in medical communications and scientific publishing, and her passion for advancing healthcare research. 

Kelly previously worked in medical communications as an Account Executive, where her role largely involved project and client management. She worked with pharmaceutical companies on a range of projects related to Medical Affairs, which were used to train field medical teams in the Respiratory and Infections department. Prior to this, Kelly worked at an open access scientific publisher as a Journal Launch Specialist. This role involved extensive liaison with academics and building editorial boards. As a result, she launched two new journals in Engineering and Health Sciences, and multiple sections within existing journals. 

Kelly completed both her BSc and MScR at Durham University in Biomedical Sciences. Her master’s thesis in Tissue Engineering was titled ‘Investigating the deposition of the extracellular matrix and bone tissue development in vitro using 2D and 3D cell culture methods’. The laboratory-based study investigated the use of a 3D scaffold to culture bone forming cells, in order to develop an in vitro bone tissue model which could then ultimately be used to model diseases such as osteoporosis. Kelly gained extensive experience in the lab, learning techniques such as mammalian cell culture, histology and stem cell differentiation.  

Outside of work, Kelly likes to cook and experiment with new recipes. She is always on the lookout for new restaurants to try and welcomes any recommendations. She enjoys exploring nature and watching sitcoms in her free time. 

Senior Associate Consultant

Liam Maddison

As Liam joins Eradigm in July 2022 as an Associate Consultant, he brings a wealth of early-stage therapeutic discovery expertise following the completion of his industry-partnered PhD programme. He has a keen interest in the application of disruptive technologies within the healthcare landscape and a desire to work with key stakeholders to revolutionise current treatment paradigms.

Undertaking his PhD research at The University of Leeds, Liam spearheaded an early-stage drug discovery campaign against a prominent epitranscriptomic regulator, with the promise to meet unmet needs in oncology and virology. The project identified a collection of novel hits against the target, culminating in the development of a potent lead compound that will be the subject of further optimisation, laying the groundwork for therapeutic development. Throughout this project, Liam managed a multi-centre collaboration and worked closely with scientists and leadership at his pharmaceutical partner company.

During his PhD studies, Liam nurtured a growing interest in the commercial aspects of the Life Sciences sector, competing in national entrepreneurship competitions and securing freelance consulting work to enhance his skillset. Here, he worked alongside top 20 pharma clients to hone his CI skills, conducting market research and conference monitoring across the cell therapy and HIV landscapes.

Prior to this, Liam completed an integrated master’s degree in Medicinal chemistry at the University of Leeds, where he discovered an interest in the pharmaceutical industry and developed expertise in small molecule drug development.

In his free time, Liam enjoys getting outdoors as much as possible, whether that be backpacking, hiking or trail running. When not out in nature, you will most likely find him anxiously watching Newcastle United, listening to his vinyl record collection, or kicking back with a good book.

Associate Consultant

Kamaal Lynch-Samms

Kamaal Joins Eradigm as an associate consultant bringing experience in psychiatric disorder treatment research and a desire to improve drug discovery pipelines.

He holds a BSc in Pharmacology from UCL where his passion for the translation of preclinical research to life-changing clinical therapies was initiated. During his degree, he conducted a research project where he screened BK channel activating drugs on the voltage dependence of BK channels using patch-clamp techniques. He was part of a team of pharmacologists and bioscientists investigating these BK channel properties for insights into respiratory diseases and potential treatments.

During his studies, Kamaal worked as a Covid-19 testing assistant in the UCL testing site where he gained a unique first-hand perspective of the impact of the global pandemic.

In between his studies, Kamaal solely produced and released a report on the most novel antidepressant and anxiolytic drugs in phase II clinical trials or later for the mental health charity Overcome, as an intern. This report was a part of the charity’s initiatives focused on providing accessible and free solutions globally for psychiatric disorders. As a business development intern for FlowCell Kamaal got to grips with the needs of end-users in the neuroscience field by liaising with potential clients to build customer profiles.

Outside of work, Kamaal is a keen fitness enthusiast playing American football competitively and being an avid gym-goer. He has a passion for Sci-Fi/fantasy books and films with his current favourite being the Dune book series by Frank Herbert due to its expansive story and philosophical overtones.

Senior Associate Consultant

Sean Abbott-Imboden

Sean joined Eradigm as an Associate Consultant in August 2022, bringing to the team his prior experience in healthcare consultancy, medical communications and data management.

Sean previously worked at a boutique life sciences consulting firm, where his role centred on conducting primary and secondary research to identify key market events and trends to support pharmaceutical companies’ strategy. Sean has worked with a plethora of pharmaceutical companies across a range of therapeutic area specific projects and cross-portfolio workstreams. Prior to this, Sean worked in Data Management for a top-10 clinical research organisation where he was responsible for reconciling and analysing clinical trial data, maintaining study documentation, and performing quality control audits of clinical trial databases.

Sean holds a BSc in Biomedical Sciences from the University of Warwick which provided him with a platform to pursue his MSc in Cancer Biology at University College London (UCL). His MSc (Distinction) consolidated his skills in critically evaluating primary and secondary scientific literature, experimental planning and interpretation of results. Diverging away from his oncology background to supplement his knowledge and support broader research efforts, his MSc dissertation focused on developing a computational in-silico model to identify drug combinations to fight COVID-19. His work contributed to a scientific publication in Nature Partner Journals – Digital Medicine.  

Sean’s academic and professional experiences have provided him with a deep understanding of the commercial and therapeutic landscape across oncology, neurology and COVID-19 as well as continually emerging fields such as digital healthcare.

Outside of work, Sean is a huge sports enthusiast. He is particularly keen on playing football, running, going to the gym and skiing. He also enjoys travelling and spending time with friends and family.

Senior Associate Consultant

Adama Anozie

Focus Therapy Areas: Rare Diseases & Orphan Drugs, Oncology, Cell Therapies

Specialist Expertise: Pricing & Market Access Strategy, Landscape Assessments, Value-Based Messaging, Medical Strategy

Education: MSc Drug Discovery & Pharma Management, University College London; BSc Pharmacy, University of Manitoba; BSc Pharmacology, McGill University

What is your focus at Eradigm?

I use my robust analytical and clinical background to help clients understand and develop their global pricing, reimbursement, and market access strategy. I work as part of Eradigm’s Market Access and Medical Strategy teams to comprehensively conduct high-quality research, analyse insights, and deliver impactful, actionable recommendations for our clients.

Who do you work with?

I typically work with global commercial and access teams, from both top 10-pharma and small to mid-size biotech companies.

What is your specialist expertise, and what types of projects do you work on?

My expertise lies in global pricing and reimbursement strategy, with a focus on rare diseases and orphan drugs in the UK and EU. I work cross-functionally, developing and delivering targeted and impactful recommendations to help clients understand market landscapes and pricing dynamics across the UK, EU, and Japan. Key capabilities include landscape mapping, global primary research with payers and stakeholders, price and revenue forecasting, and value messaging development

What did you do before Eradigm?

Prior to Eradigm, I worked on developing PRMA strategy for clients across the UK, EU, and US. I was involved in consulting projects helping clients understand pricing and revenue potential by conducting and analysing primary research, as well as building price and revenue modelling tools accounting for country-specific Health Technology Assessment and reimbursement systems, client and competitor strategy, and launch sequencing

What are your passions outside of work? Outside of work, I can usually be found in or adjacent to a bakery. I also enjoy playing football, visiting art exhibitions, watching anime, and creating playlists for extremely specific moments of life

Associate Consultant

Isaac Bryan

Isaac joined Eradigm as an Associate Consultant in September 2022, bringing with him a breadth of experience working in pharmaceutical market research. 

In his previous role, Isaac focused on conducting primary and secondary quantitative research, in order to provide actionable insights that would answer clients research needs and objectives. Isaac has experience utilising a wide array of complex research methodologies and working with some of the largest pharmaceutical companies around the world. It was during this time that he developed a real passion for global healthcare.

Isaac holds a Bsc in Psychology from the University of Manchester through which helped him gain extensive knowledge in areas such as behavioural psychology, cognitive neuroscience, quantitative research methodologies, and statistics and data analysis. For his dissertation he carried out his own research study, investigating the effects of loss aversion on visual extrapolation under risk. 

Outside of work, Isaac is a big sports enthusiast with a particular passion for football, going to the gym and skiing. However Isaac is also big into his travel, music and cooking.

Associate Consultant

Joshua Wyatt

Joshua joined Eradigm in September 2022 as an Associate Consultant, bringing his relevant academic and professional experience alongside.

Joshua holds an Honours BSc from the University of Toronto in Canada, from a joint program with the School of the Environment and the Department of Pharmacology and Toxicology within the Faculty of Medicine. Here, Joshua discovered his interest in chemical pollutants, antibiotic resistance, and climate change. In the midst of his undergrad, Joshua participated on an academic exchange to the University of Amsterdam, Netherlands, where he gained a global view on the pharmaceutical industry. Further his studies, Joshua went forth to complete a Masters degree in Drug Discovery and Pharma Management at the UCL School of Pharmacy in London, England. In his dissertation, Joshua studied the recent trends in Alzheimer’s disease drug development and clinical trial research, and discovered important findings in the commercial operations of the neurodegenerative disease space.

Alongside his undergraduate studies, Joshua worked at a small toxicological research organization, contributing to reports and datasets on various chemicals around the globe, and how they bioaccumulate within different species and their food systems. Alongside his graduate dissertation, Joshua worked an internship with Clarivate Analytics, where he learned a vast amount about life science consulting, and the various projects, deliverables, and resources many different companies require to advance their pipeline and revenue.

Outside of academia and work, Joshua coached local swim teams and helped organize community events around Toronto, making great friends and memories along the way. In his spare time, Joshua loves to cycle around the countryside, play basketball with friends, and practice his musical instruments.